News

AbbVie's Emrelis is the first non-small cell lung cancer therapy approved for patients with high c-Met expression levels who ...
Alabama is instituting its first major regulation on e-cigarettes and vaping devices under legislation signed Wednesday by ...
The PAM Health Rehabilitation of Tulsa held free mini screenings to show stroke survivors a new FDA-approved rehabilitation ...
Orchestra BioMed's AVIM earns FDA breakthrough designation, sparking investor optimism. Click here to read why OBIO stock is ...
FDA will implement a secure generative AI system across all centers by June 30, aiming to streamline internal reviews and ...
The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a rare type of ovarian ...
The FDA has granted accelerated approval to avutometinib (VS-6766) plus defactinib (VS-6063) for the treatment of adult ...
The Trump administration argues that Kansas, Idaho, and Missouri have no standing sue the FDA over abortion pills in the Northern District of Texas.
The FDA has approved Johnson & Johnson’s drug Imaavy for the treatment of generalized myasthenia gravis, a chronic autoimmune neuromuscular disorder. The approval covers adults and pediatric patients ...
Here is a recap of every FDA approval announced by the regulatory agency in the month of April, spanning various cancer types ...
announced today that the U.S. Food and Drug Administration (FDA) has approved its transcatheter aortic valve replacement (TAVR) therapy, the SAPIEN 3 platform, for severe aortic stenosis (AS ...
The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's drug to treat a type of muscle-weakening ...